Michihiro Mutoh

14PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpidemiological methodsPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 30, 2026
Curcumin Suppresses Growth of Recurrent Colorectal Adenoma After Endoscopic Resection: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.

|May 04, 2026
Identification of ANT2 as a Druggable Target for Endocrine-Resistant ERα-Positive Breast Cancer.

|Apr 21, 2026
Association between Low-Dose Aspirin Use and Colorectal Cancer Incidence Using Japanese Large-Scale Health Insurance Claims Data.

|Aug 31, 2023
Cost-effectiveness of preventive aspirin use and intensive downstaging polypectomy in patients with familial adenomatous polyposis: A microsimulation modeling study.

Eiko Saito, Michihiro Mutoh, Hideki Ishikawa

|Sep 09, 2022
Resveratrol inhibits development of colorectal adenoma via suppression of LEF1; comprehensive analysis with connectivity map.

Hironori Wada, Yasushi Sato, Shota Fujimoto

|Sep 08, 2022
Aspirin-Mediated Prevention of Colorectal Adenomas Recurrence is Affected by Blood Biochemistry and Nutritional Intake.

Naohisa Yoshida, Hideki Ishikawa, Takahiro Otani

Pageof 3

Frequent Collaborators

4 joint publications

Hideki Ishikawa

3 joint publications

Motoki Iwasaki

3 joint publications

Tetsuji Takayama

2 joint publications

Nagisa Mori